 |
MAGE-A3 cancer therapeutic Trojan peptide vaccine |
|---|---|
| Trade Name | |
| Orphan Indication | Squamous cell carcinoma of head and neck |
| USA Market Approval | USA |
| USA Designation Date | 2008-11-24 00:00:00 |
| Sponsor | Gliknik, Inc.;801 W. Baltimore Street, Suite 501A;Baltimore, Maryland, 21201 |
